Please note that we charge an extra fee for prenatal analysis.
Prenatal Testing Is Given the Highest Priority at CENTOGENE
Prenatal genetic testing for congenital and early onset diseases. Early and accurate identification of disease-causing mutations in "at-risk" families before birth. All monogenic diseases can be detected, even at the early stages of pregnancy.
The choice of the appropriate testing strategy and a quick response are key factors to minimize the stress.
This is why CENTOGENE offers a turnaround time of ten business days for most prenatal analyses (known variants, deletion/duplication analysis, single gene sequencing) and of less than 15 business days for NGS (next generation sequencing) analyses (CentoXome®, CentoGenome® and CentoArray®). In addition, our medical experts are always available for your support before, during and after the analysis.
- Chorionic villi
- Amniotic fluid
- Fetal DNA
- Cord blood (for late pregnancies) as possible material
You have the option to send us tubes with already cultivated cells. Alternatively, we offer CentoCulture®, our cell cultivation service.
Please always contact us prior to every prenatal sample sending to prevent transport delays and to allow us to give the analysis top priority. Please provide the following mandatory information :
- Logistics tracking number of sample shipment
- Requested analysis
- Physician's contact information
All prenatal cases are specifically assigned to our dedicated prenatal team who takes the utmost individual care.
Logistic and Communication Manager
+49 381 80113 663
For timely sample registration over the weekend, all prenatal samples must reach our laboratory no later than 3:30 p.m. CEST on Friday or 2:00 p.m. CEST on Saturday.
Defining the Clinical Spectrum of Rare Disorders
Many rare disorders, despite being considered syndromic, may manifest with only a single clinical symptom. A CENTOGENE-led epidemiological clinical study provided impressive evidence for the […]
Recognition of CENTOGENE's Scientific Expertise
Review articles constitute a unique type of scientific publication, as they summarize, rather than present, observations and interpretations. In prestigious journals, they are commonly provided by […]
Turning Rare Disease Networks into Knowledge
CENTOGENE’s well-recognized expertise in Gaucher disease (GD) has helped to establish a global network of physicians interested in and aware of this rare metabolic disorder. The fact that CENTOGENE […]
Transforming the Way You Analyze Genetic Data: An Inside Look at CentoCloud's New Innovation
Watch our on-demand webinar to enable rapid bioinformatic analysis and interpretation of Next Generation Sequencing (NGS) data.
CentoCloud – Discover a New World of Medical Diagnostics
Join us on November 2 as we open the digital doors to a new world of medical diagnostics. Throughout the webinar, our speakers, Ana Popic, Head of CENTOGENE Belgrade, and Martin Shumanov, Regional […]
Rewrite the Future of Rare Diseases With Multiomics
Our speakers, Maximilian Schmid M.D., Chief Commercial Officer – Diagnostics, and Prof. Peter Bauer M.D., Chief Genomic Officer, will highlight the power of multiomics in establishing a complete […]